P020 Incidence of Suboptimal Response to First-Line Anti-TNF Therapy in Patients with IBD in Argentina: Results from the EXPLORE Study
Am J Gastroenterol
.
2020 Dec 1;115(Suppl 1):S5.
doi: 10.14309/01.ajg.0000722876.29472.ed.
Authors
Zubiaurre Ignacio
1
,
Pedreira Silvia C
2
,
De Maria Julio
3
,
Balderramo Domingo C
4
,
Brion Laura
5
,
Leonardi Daiana B
5
,
Guimaraens Patricia N
5
,
Fadeeva Olga
6
,
De Paula Juan A
7
Affiliations
1
Hospital Británico de Buenos Aires, Buenos Aires, Argentina.
2
Hospital Alemán, Buenos Aires, Argentina.
3
Hospital Italiano La Plata, La Plata, Argentina.
4
Hospital Privado Centro Médico de Córdoba & Instituto Universitario de Ciencias Biomédicas de Córdoba, Cordoba, Argentina.
5
Medical Affairs, Takeda Pharma S.A., Buenos Aires, Argentina.
6
Medical Affairs, Takeda Pharmaceutical International AG, Singapore, Singapore.
7
Hospital Italiano Buenos Aires, Buenos Aires, Argentina.
PMID:
33566494
DOI:
10.14309/01.ajg.0000722876.29472.ed
No abstract available